Contact Me - QA VALIDATION ENGINEER CONSULTANT (UK)

+44 79 19 49 39 39 wilsonblaney@gmail.com

Home
LinkedIn Profile
- CV
- Clients
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog
- Privacy Policy
- Copyright

Select Page

MHRA Drug Safety Alerts

Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines January 9, 2019
Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation January 9, 2019

MHRA Recall Notices

Class 2 Medicines Recall: Actavis Group PTC EHF - recall of batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets January 3, 2019
Class 2 Medicines Recall: Teva UK Limited and Mylan - recall of some Valsartan containing products November 30, 2018

FDA Recall Notices

RXBAR Recalls Certain Varieties of Bars Due to a Potential Undeclared Peanut Allergen January 16, 2019
Voluntary Recall Notice of El Guapo Chile Habanero and Chile Pasilla-Ancho Pouches Due to Unlabeled Peanut Allergen January 16, 2019

Categories

EudraLex
FDA Latest News
MHRA News
Novartis
Pharmaceutical Validation Blog
Process Validation Engineer

Recent Posts

Doctors pounce on ‘alarmist,’ ‘horrifying’ Novartis heart-failure ad February 23, 2016
Latest Novartis News February 18, 2016

Home
LinkedIn Profile
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog

Designed by Elegant Themes | Powered by WordPress